Working with our strategic partners, the National Foundation for Cancer Research and AIM-HI Accelerator Fund (AIM-HI), AFCR have launched the inaugural Women’s Venture Competition in 2020.
The AIM-HI Women’s Venture Competition is a first-of-its-kind program that combines extensive coaching, networking and financial opportunities to accelerate female-led oncology innovations onto the path to clinical trials and, eventually, new effective therapeutics, diagnostics and digital health solutions that could save patients’ lives.
The 2021 Women’s Venture Competition is Now Open For Applications!
Women-led, pre-Series-A cancer technology companies are eligible to apply. One winning business will receive a total of US$1 million investment led by AIM-HI. Outside of the investment, “Rising Star” and “Most Innovative Technology” prizes will be awarded to chosen contestants as well.
Applications are due by May 15, 2021. Learn more about the program and APPLY NOW!
Click here to download the 2021 AIM-HI Women’s Venture-Competition flyer.
